Nanoparticle Albumin-Bound-Paclitaxel in the Treatment of Metastatic Urethral Adenocarcinoma: The Significance of Molecular Profiling and Targeted Therapy
Primary urethral cancer is rare and accounts for only 0.003% of all malignancies arising from the female genitourinary tract. Due to the rarity of this disease, no consensus exists regarding the optimal therapeutic approach. Nanoparticle albumin-bound-paclitaxel has been shown to be effective in the...
Saved in:
Main Authors: | Yasmin M. Abaza, Carlos Alemany |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Case Reports in Urology |
Online Access: | http://dx.doi.org/10.1155/2014/489686 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sub-Tenon Injections of Triamcinolone Acetonide Had Limited Effect on Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound-Paclitaxel (Abraxane)
by: Naoki Matsuoka, et al.
Published: (2015-01-01) -
Peptide Aptamer–Paclitaxel Conjugates for Tumor Targeted Therapy
by: Xinyang Shen, et al.
Published: (2024-12-01) -
Alfa-Fetoprotein-Producing Female Primary Urethral Adenocarcinoma with Neuroendocrine Differentiation
by: Takao Natsuyama, et al.
Published: (2019-01-01) -
Tennis Rehabilitation Training-Assisted Paclitaxel Nanoparticles in Treatment of Lung Tumor
by: Di Hu, et al.
Published: (2020-01-01) -
Tiptoeing on Metastatic Adenocarcinoma of the Lung
by: Arupreet Kochar, et al.
Published: (2019-01-01)